Oncology and Hematology - Global Oncology Academy

Episodes 289-304 of 485

Interprofessional Coordination of Adverse Event Management
Interprofessional Coordination of Adverse Event Management
MinuteCE®
Interprofessional Coordination of Adverse Event Management
1.25 program credits
- Nadia Harbeck, MD, PhD
1.25 program credits
Mastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and Side Effect Management
Mastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and Side Effect Management
CME/CE
Mastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and Side Effect Management
1.00 credit
- Amir T. Fathi, MD
- Courtney DiNardo, MD
- Brian A. Jonas, MD, PhD
1.00 credit
Noncovalent BTK Inhibitors: New Targeted Options for Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Noncovalent BTK Inhibitors: New Targeted Options for Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
CME/CE
Noncovalent BTK Inhibitors: New Targeted Options for Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
1.00 credit
- Matthew S. Davids, MD, MMSc
1.00 credit
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Project Oncology®
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
- Betsy O'Donnell, MD
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Project Oncology®
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
- Betsy O'Donnell, MD
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Project Oncology®
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
- Betsy O'Donnell, MD
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Project Oncology®
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
- David Braun
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Project Oncology®
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
- David Braun, MD, PhD
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Project Oncology®
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
- Munir Ghesani, MD
Enhancing HCC Outcomes Through Multidisciplinary Care
Enhancing HCC Outcomes Through Multidisciplinary Care
Project Oncology®
Enhancing HCC Outcomes Through Multidisciplinary Care
- Charles Turck, PharmD, BCPS, BCCCP
- Hannah Lee, MD
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Project Oncology®
Optimizing HCC Screening: Strategies to Overcome Common Barriers
- Hannah Lee, MD
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
Project Oncology®
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
- Robert Wong, MD
Key Highlights from SNMMI 2024
Key Highlights from SNMMI 2024
Project Oncology®
Key Highlights from SNMMI 2024
An Overview of the Fundamentals of PET-CT Imaging
An Overview of the Fundamentals of PET-CT Imaging
Project Oncology®
An Overview of the Fundamentals of PET-CT Imaging
An Exploration of Multiple Myeloma Treatments
An Exploration of Multiple Myeloma Treatments
Project Oncology®
An Exploration of Multiple Myeloma Treatments
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
Project Oncology®
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
- Matt Birnholz, MD
- Saad Kenderian M.B, Ch.B

19/11